212 related articles for article (PubMed ID: 32194742)
1. Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells.
Sumransub N; Jirapongwattana N; Jamjuntra P; Thongchot S; Chieochansin T; Yenchitsomanus PT; Thuwajit P; Warnnissorn M; O-Charoenrat P; Thuwajit C
Oncol Lett; 2020 Mar; 19(3):2422-2430. PubMed ID: 32194742
[TBL] [Abstract][Full Text] [Related]
2. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
3. [T cells recognizing EBV-epitopes arose in co-culture of peripheral blood mononuclear cells from EB-infected patients and dendritic cells loaded with LMP2-mixed peptides].
Xing YP; Cen XN; Tong CR; Gu JY; Cai P; Tao XY; Jin X; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):392-6. PubMed ID: 18426672
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
5. [Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide].
Liu JW; Lu X; Yang ZM; Deng LJ; Yang L
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):840-846. PubMed ID: 29045966
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell gene therapy.
Onaitis M; Kalady MF; Pruitt S; Tyler DS
Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
[TBL] [Abstract][Full Text] [Related]
7. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
[TBL] [Abstract][Full Text] [Related]
8. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells.
Parajuli P; Mathupala S; Sloan AE
Neurosurgery; 2004 Nov; 55(5):1194-204. PubMed ID: 15509326
[TBL] [Abstract][Full Text] [Related]
9. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
Ohta K; Yamaguchi Y; Shimizu K; Miyahara E; Toge T
Anticancer Res; 2002; 22(5):2597-606. PubMed ID: 12529970
[TBL] [Abstract][Full Text] [Related]
10. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Dec; 75(3):217-27. PubMed ID: 14611813
[TBL] [Abstract][Full Text] [Related]
11. A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model.
El-Ashmawy NE; El-Zamarany EA; Salem ML; Khedr EG; Ibrahim AO
Mol Immunol; 2019 Jul; 111():106-117. PubMed ID: 31051312
[TBL] [Abstract][Full Text] [Related]
12. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
13. [Cytotoxicity of dendritic cells pulsed by CpG ODN on ovarian carcinoma cells: in vitro experiment with ovarian carcinoma cells].
Ye MZ; Li HL; Han LY
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):778-82. PubMed ID: 17565850
[TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H
Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099
[TBL] [Abstract][Full Text] [Related]
15. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
[TBL] [Abstract][Full Text] [Related]
16. "Double hit" strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by targeting breast cancer stem cells.
Acikgoz E; Duzagac F; Guven U; Yigitturk G; Kose T; Oktem G
Int Immunopharmacol; 2022 Jun; 107():108684. PubMed ID: 35272171
[TBL] [Abstract][Full Text] [Related]
17. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
[TBL] [Abstract][Full Text] [Related]
18. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
[TBL] [Abstract][Full Text] [Related]
20. [Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells].
Shi YJ; Ren HY; Cen XN; Dong YJ; Ma MX; Zhao YL; Zhu Y; Yu JR
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):107-11. PubMed ID: 18646691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
